B cell depletion in Idiopathic Inflammatory Myopathy
Principal Investigator:
Jo Edwards, Shabina Sultan, David Isenberg, University College, London
Study Design:
Phase 1 open, at University College, London
Types & Number of IIM Studied:
Active Polymyositis or Dermatomyositis (N = 5)
Entry Criteria:
Definite Polymyositis or Dermatomyositis by Bohan and Peter criteria; Refractory to standard therapy
IMACS Core Set Measures Included:
MITAX, Physician and Patient Global Activity Assessment, Manual Muscle Testing (MMT-8), Health Assessment Questionnaire, muscle enzymes; Health Related Quality of Life by SF-36
Other Measures Included:
Myometry, Activities of Daily Living, rash, B cells, serology
Primary Outcome:
Myometry and Creatine kinase
Study Duration:
6 months
Funding:
Myositis Support Group UK
Comments:
Study has completed enrollment
Contact:
-
David A. Isenberg, M.D., F.R.C.P.
ARC Diamond Jubilee Professor of Rheumatology -
University College London
Centre for Rheumatology, University College London
Arthur Stanley House
40-50 Tottenham Street
London W1P 9PG UK
d.isenberg@ucl.ac.uk
Return to Therapeutic Studies listing
